Frontlight ResearchEarly access
Trial site
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Multiple myeloma2 trials
- Amyloidosis1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Depression1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Stroke1 trial
- Phase
- Phase 311 trials
- Phase 2/31 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC10 trials
- Nuvalent Inc.1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026